Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, PLAB (UK), FCPS (Gastroenterology)
Internal Medicine Specialist
MBBS, PLAB (UK), FCPS (Gastroenterology)
Diabetologist
M.B.B.S., DipDiab
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Cardiologist
M.B.B.S., M.Phil (Clinical Pharmacology), Dip. Diabetes, Ph.D Scholar (Clinical Pharmacology), M.D (Cardiology)
Cardiologist
M.B.B.S., M.Phil (Clinical Pharmacology), Dip. Diabetes, Ph.D Scholar (Clinical Pharmacology), M.D (Cardiology)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), M.C.P.S
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), M.C.P.S
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Consultant Physician
MBBS, MCPS, FCPS Internal Medicine
Internal Medicine Specialist
MBBS, MCPS (Family Medicine), CEFM
Internal Medicine Specialist
MBBS, FCPS
Internal Medicine Specialist
M.B.B.S (LUMS), D.T.C.D (OICD), M.D.E (DUHS)
Internal Medicine Specialist
M.B.B.S (LUMS), D.T.C.D (OICD), M.D.E (DUHS)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures